Aberrant Cdx2 expression in endometrial lesions with squamous differentiation: important role of Cdx2 in squamous morula formation

Human Pathology

Volumn 39, Issue 7, 2008, Pages 1072-1079

  Wani, Yoji ^a   Notohara, Kenji ^a   Saegusa, Makoto ^b   Tsukayama, Choutatsu ^a  

^a KURASHIKI CENTRAL HOSPITAL   (Japan)

^b KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Catenin; Cdx2; Endometrioid carcinoma; Morulas

Indexed keywords

BETA CATENIN; TRANSCRIPTION FACTOR CDX2;

ARTICLE; CELL DIFFERENTIATION; CORRELATION ANALYSIS; ENDOMETRIUM CARCINOMA; ENDOMETRIUM CYTOLOGY; FEMALE; GENE MUTATION; HUMAN; HUMAN TISSUE; HYPERPLASIA; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MORULA; POLYP; PROTEIN EXPRESSION; STATISTICAL SIGNIFICANCE;

BETA CATENIN; CARCINOMA, ENDOMETRIOID; CARCINOMA, SQUAMOUS CELL; CELL COUNT; CELL NUCLEUS; CELL TRANSFORMATION, NEOPLASTIC; ENDOMETRIAL HYPERPLASIA; ENDOMETRIAL NEOPLASMS; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HOMEODOMAIN PROTEINS; HUMANS; IMMUNOENZYME TECHNIQUES; TUMOR MARKERS, BIOLOGICAL;

EID: 45049088813     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2007.07.019     Document Type: Article

References (22)

1. Suh E., Chen L., Taylor J., et al. A homeodomain protein related to caudal regulates intestine-specific gene transcription. Mol Cell Biol 14 (1994) 7340-7351
2. Silberg D.G., Swain G.P., Suth E.R., et al. Cdx1 and cdx2 expression during intestinal development. Gasteroenterology 119 (2000) 961-971
3. Barbareschi M., Murer B., Colby T.V., et al. Cdx-2 homeobox gene expression is a reliable marker of colorectal adenocarcinoma metastases to the lungs. Am J Surg Pathol 27 (2003) 141-149
4. Werling R., Yaziji H., Bacchi C., et al. CDX2, a highly sensitive and specific marker of adenocarcinoma of intestinal origin. Am J Surg Pathol 27 (2003) 303-310
5. Groisman G., Meir A., and Sabo E. The value of Cdx2 immunostaining in differentiating primary ovarian carcinoma from colonic carcinoma metastatic to the ovaries. Int J Gynecol Pathol 23 (2003) 52-57
6. Logani S., Oliva E., Arnell P.M., et al. Use of novel immunohistochemical markers expressed in colonic adenocarcinoma to distinguish primary ovarian tumors from metastatic colorectal carcinoma. Mod Pathol 18 (2005) 19-25
7. Tornillo L., Moch H., Diener P., et al. Cdx2 immunostaining in primary and secondary ovarian carcinoma. J Clin Pathol 57 (2004) 641-643
8. Moskaluk C.A., Zhang H., Powell S.M., et al. Cdx2 protein expression in normal and malignant human tissues: an immunohistochemical survey using tissue microarrays. Mod Pathol 16 (2003) 913-919
9. De Lott L., Morrison C., Suster S., et al. Cdx2 is a useful marker of intestinal-type differentiation. Arch Pathol Lab Med 129 (2005) 1100-1105
10. Mazziotta R., Borczuk A., Powell C., et al. CDX2 immunostaining as a gastrointestinal marker: expression in lung carcinomas is a potential pitfall. Appl Immunohistochem Mol Morphol 12 (2005) 55-60
11. Kaimaktchiev V., Terracciano L., Tornillo L., et al. The homeobox intestinal differentiation factor CDX2 is selectively expressed in gastrointestinal adenocarcinomas. Mod Pathol 17 (2004) 1392-1399
12. Park K., Bramlage M., Pirog E., et al. Cdx2 immunohistochemical staining patterns in mucinous neoplasms of the female genital tract. Mod Pathol 18 Suppl (2005) 199A
13. Saegusa M., and Okayasu I. Frequent nuclear β-catenin accumulation and associated mutations in endometrioid-type endometrial and ovarian carcinomas with squamous differentiation. J Pathol 194 (2001) 59-67
14. Irving J., Catasus L., Gallardo A., et al. Synchronous endometrioid carcinomas of the uterine corpus and ovary: alterations in the β-catenin (CTNNB1) pathway are associated with independent primary tumors and favorable prognosis. Hum Pathol 36 (2005) 605-619
15. Brachtel E., Sanchez-Estevez C., Moreno-Bueno G., et al. Distinct molecular alterations in complex endometrial hyperplasia (CEH) with and without immature squamous metaplasia (squamous morules). Am J Surg Pathol 29 (2005) 1322-1329
16. Ohta S., Catasus L., Matias-Guiu X., et al. Molecular pathology of atypical polypoid adenomyoma of the uterus. Hum Pathol 34 (2003) 784-788
17. Nakatani Y., Masudo K., Nozawa A., et al. Biotin-rich optically clear nuclei express estrogen receptor-β: tumors with morules may develop under the influence of estrogen and aberrant β-catenin expression. Hum Pathol 35 (2004) 869-874
18. Gamachi A., Kashima K., Daa T., et al. Aberrant intranuclear localization of biotin, biotin-binding enzymes and beta-catenin in pregnancy-related endometrium and morule-associated neoplastic lesions. Mod Pathol 16 (2003) 1124-1131
19. Crum C, Lee K. Diagnostic gynecologic and obstetric pathology. Philadelphia: Elsevier Saunders. pp 525-529, 553-558.
20. Silverberg S., and Kurman R. Tumors of the uterine corpus and gestational trophoblastic disease. Atlas of tumor pathology, third series, fascicle 3 (1991), Armed Forces Institute of Pathology, Washington (DC) 54-62
21. Shih H., Shiozawa T., Miyamoto T., et al. Nuclear localization of β-catenin is correlated with the expression of cyclin D1 in endometrial carcinomas. Anti Cancer Res 23 (2003) 3749-3754
22. Saegusa M., Hashimura M., Kuwata T., et al. β-catenin simultaneously induces activation of the p53-p21WAF1 pathway and overexpression of cyclin D1 during squamous differentiation of endometrial carcinoma cells. Am J Pathol 164 (2004) 1739-1749